Bulletin
Investor Alert

New York Markets Open in:

VBI Vaccines Inc.

NAS: VBIV

GO
/marketstate/country/us

Before the Bell

 --Real time quotes

Jan 22, 2021, 7:01 a.m.

/zigman2/quotes/201705917/composite

$

3.06

Change

-0.02 -0.65%

Volume

Volume 6,032

Real time quotes

/zigman2/quotes/201705917/composite

Previous close

$ 3.08

$ 3.08

Change

-0.22 -6.53%

Day low

Day high

$3.06

$3.52

Open

52 week low

52 week high

$0.69

$6.93

Open

Insider Actions for VBI Vaccines Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
04/24/2020 Perceptive Advisors LLC
9,090,909   Acquisition at $1.1 per share. 9,999,999
10/04/2019 Francisco Diaz-Mitoma
Chief Medical Officer
40,000   Acquisition at $0.5 per share. 20,000
09/30/2019 Jeffrey R. Baxter
CEO, President; Director
150,000   Acquisition at $0.5 per share. 75,000
09/30/2019 Francisco Diaz-Mitoma
Chief Medical Officer
14,500   Acquisition at $0.5 per share. 7,250
09/23/2019 Perceptive Advisors LLC
20,000,000   Acquisition at $0.5 per share. 10,000,000
06/27/2019 Francisco Diaz-Mitoma
Chief Medical Officer
8,000   Acquisition at $1.07 per share. 8,560
06/20/2019 Francisco Diaz-Mitoma
Chief Medical Officer
42,000   Acquisition at $0.89 per share. 37,380
06/20/2019 Francisco Diaz-Mitoma
Chief Medical Officer
10,000   Acquisition at $0.78 per share. 7,800
06/19/2019 Jeffrey R. Baxter
CEO, President; Director
144,000   Acquisition at $0.73 per share. 105,120
06/19/2019 Nell Beattie
Chief Business Officer
8,000   Acquisition at $0.74 per share. 5,920
06/17/2019 Perceptive Advisors LLC
1,000,000   Acquisition at $0.62 per share. 620,000
06/14/2019 Jeffrey R. Baxter
CEO, President; Director
31,250   Derivative/Non-derivative trans. at $0 per share. 0
06/14/2019 David Evander Anderson
Chief Scientific Officer
21,875   Derivative/Non-derivative trans. at $0 per share. 0
06/14/2019 Steven H. Gillis
Director
18,750   Derivative/Non-derivative trans. at $0 per share. 0
06/14/2019 Nell Beattie
Chief Business Officer
6,250   Derivative/Non-derivative trans. at $0 per share. 0
06/14/2019 Michel de Wilde
Director
12,500   Derivative/Non-derivative trans. at $0 per share. 0
01/31/2019 David Evander Anderson
Chief Scientific Officer
25,000   Award at $0 per share. 0
01/31/2019 Avi Mazaltov
Head Global MFG&GM-SciVac Ltd.
90,000   Award at $0 per share. 0
01/31/2019 Nell Beattie
Chief Business Officer
15,000   Award at $0 per share. 0
01/31/2019 Christopher McNulty
CFO and Head of BD
25,000   Award at $0 per share. 0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
0 Sales
0
0
Last 6 months
0 Purchases
0 Sales
0
0
Last 12 months
1 Purchases
0 Sales
9,090,909
0

Officers and Executives

Mr. Jeffrey R. Baxter
President, Chief Executive Officer & Director
Mr. Christopher McNulty
CFO, Director & Head-Business Development
Dr. David Evander Anderson
Chief Scientific Officer
Dr. Francisco Diaz-Mitoma
Chief Medical Officer
Ms. Nell Beattie
Chief Business Officer
Mr. Avi Mazaltov
Global Head-Manufacturing
Mr. Misha Nossov
VP-Supply Chain & Information Systems
Ms. Athena Kartsaklis
Senior Vice President-Finance
Mr. T. Adam Buckley
Vice President-Business Development
Dr. Vlad Popovic
VP-Clinical Development & Medical Affairs
Ms. Nicole Anderson
Director-Corporate Communications & IR
Dr. Steven H. Gillis
Chairman
Mr. Damian Braga
Independent Director
Dr. Michel de Wilde
Independent Director
Dr. Blaine H. McKee
Independent Director
Ms. Joanne Cordeiro
Independent Director
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.